Ales for ALS
ALS TDI Pipeline Update
Dr. Steve Perrin will present an update on the ALS TDI drug development pipeline...
20 ALS Clinical Trials You Should Know About
A discussion about the latest ALS clinical trials.
Tirasemtiv phase IIB results in
Tirasemtiv fails to meet its primary endpoint, an effect on progression rate.
How are we going to invest #IceBucketChallenge funds?
Our CEO, Dr. Steve Perrin, outlines how we will invest these dollars to accelera...
Meet YFALS Ambassadors
Meet the 2014 Young Faces of ALS at this year's National Corntoss Challenge (May...
Company Matching Gift
Make your contribution count for double!
In The Spotlight
SOD1 Off ALS
Emerging SOD1 antibodies aim to stop ALS in its tracks.
What's next after dex?
New energy boosters for PALS are beginning to emerge
Therapy to a T?
Low-dose IL-2, an emerging Treg booster shot, approaches phase I/II.